Intraocular Inflammation Control and Changes in Retinal and Choroidal Architecture in Refractory Non-Infectious Uveitis Patients after Adalimumab Therapy

Background: Non-infectious uveitis represents a leading cause of visual impairment, and inflammation control represents a major priority in tackling visual acuity loss due to complications such as macular edema; different immunomodulatory drugs are currently being used, including anti-TNF-alpha Adal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirani, Vittorio, Pelliccioni, Paolo, De Turris, Serena, Rosati, Alessandro, Franceschi, Alessandro, Pasanisi, Pierangelo, Gesuita, Rosaria, Nicolai, Michele, Mariotti, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074084/
https://www.ncbi.nlm.nih.gov/pubmed/32069898
http://dx.doi.org/10.3390/jcm9020510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074084/
https://www.ncbi.nlm.nih.gov/pubmed/32069898
http://dx.doi.org/10.3390/jcm9020510

Ejemplares similares